Current methods for monitoring specific molecules in the living body, such as the continuous glucose monitor, rely on the enzymatic or chemical reactivity of their targets, and thus are not generalizable to new targets. For this reason, only a handful of metabolites and neurotransmitters can currently be measured in vivo. Against this background, we are developing a molecular measurement platform that: (1) has been demonstrated able to work in the living body and (2) is independent of the reactivity of its targets and thus is general
Abstract
Robert Batchelor completed both his MS in Pharmacology and BS in Biochemistry at the University of Washington in Seattle, USA. Since then, he has gained over twenty years’ experience in the biotech industry and has launched over 50 products to market at several companies, including ThermoFisher. He is an expert on developing electrochemical aptamer-based sensors based on his experience at four startup companies in the US and Australia, including Base Pair Biotechnologies in Houston, Texas, and former wearable medicine sensing industry leader Eccrine Systems in Cincinnati, Ohio. He is currently the Head of Biosensors at Nutromics in Melbourne, Australia
Nanoelectronics Biosensors
Lab-on-a-chip and multiplexed sensors
Microfluidics and immobilisation technology
Enzyme-based biosensors
Novel transducers and Photonic Sensor Technologies
Bioelectronics and Bioinstrumentation
Application of biosensors in drug Delivery and clinical chemistry